EMD Serono, Inc.

EMD Serono - the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada - is engaged in the discovery, research and development of medicines for patients with difficult to treat diseases. Building on a proven legacy and deep expertise in neurology, fertility and endocrinology, the company is committed to transforming lives by developing and delivering meaningful solutions that help address the therapeutic and support needs of individual patients. EMD Serono is developing potential new oncology and immuno-oncology medicines while continuing to explore potential therapeutic options for diseases such as psoriasis, lupus and MS. Today, the company has approximately 1,500 employees around the country with commercial, clinical and research operations based in the company's home state of Massachusetts.

• Who We Are
• Our Expertise
• Our R&D Approach